Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial

Authors: Joseph, David, Denham, James W., Steigler, Allison, Lamb, David S., Spry, Nigel A., Stanley, John, Shannon, Tom, Duchesne, Gillian, Atkinson, Chris, Matthews, John H.L., Turner, Sandra, Kenny, Lizbeth, Christie, David, Tai, Keen-Hun, Gogna, Nirdosh Kumar, Kearvell, Rachel, Murray, Judy, Ebert, Martin A., Haworth, Annette, Delahunt, Brett, Oldmeadow, Christopher, Attia, John

Source: International journal of radiation oncology, biology, physics. 106(4):693-702

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100099987997.0x000001&indx=1&recIds=ETOCvdc_100099987997.0x000001

T1-2 anal carcinoma requires elective inguinal radiation treatment – The results of Trans Tasman Radiation Oncology Group study TROG 99.02

Authors: Matthews, John H.L., Burmeister, Bryan H., Borg, Martin, Capp, Anne L., Joseph, David, Thompson, Kerin M., Thompson, Paul I., Harvey, Jennifer A., Spry, Nigel A.

Source: In Radiotherapy and Oncology 2011 98(1):93-98

The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: Results from the MRC RT01 trial (ISRCTN47772397)

Authors: Dearnaley, David P., Sydes, Matthew R., Langley, Ruth E., Graham, John D., Huddart, Robert A., Syndikus, Isabel, Matthews, John H.L., Scrase, Christopher D., Jose, Chakiath C., Logue, John, Stephens, Richard J.

Source: In Radiotherapy and Oncology 2007 83(1):31-41

Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: A report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group

Authors: Gogna, Nirdosh Kumar, Matthews, John H.L., Turner, Sandra L., Mameghan, Heidi, Duchesne, Gillian M., Spry, Nigel, Berry, Martin P., Keller, Jacqui, Tripcony, Lee

Source: In Radiotherapy and Oncology 2006 81(1):9-17

Corrigendum to “Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: A report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group” [Radiother Oncol 81 (2006) 9–17]

Authors: Gogna, Nirdosh Kumar, Matthews, John H.L., Turner, Sandra L., Mameghan, Hedy, Duchesne, Gillian M., Spry, Nigel, Berry, Martin P., Keller, Jacqui, Tripcony, Lee

Source: In Radiotherapy and Oncology 2007 83(2):215-215